Tuning daytime and evening light did not improve older adults' sleep
In a 12-person crossover trial, blue-enriched daytime light with reduced evening blue did not cut time spent awake at night, though it nudged a brainwave marker of sleep.
For how we live.
In a 12-person crossover trial, blue-enriched daytime light with reduced evening blue did not cut time spent awake at night, though it nudged a brainwave marker of sleep.
Two small pilot studies in 18-to-25-year-olds found morning bright light on its own shifted circadian timing little, while adding a timed schedule and evening blue-blockers advanced it about 35 minutes.
It is a strip of tape over the lips at night, meant to force nose breathing. The idea is simple; the safety caveat is the part that matters most.
The remedies that work are the ones matched to the cause — nose, mouth, tongue or palate. Here is what the trials support, and the sign that means see a doctor first.
A meta-analysis of 27 studies found a dose-response pattern that runs against the nightcap logic: the sedative effect needs a high dose, and the REM disruption starts at a low one.
Participants on Magtein scored better on memory and reaction-time tests after six weeks. On sleep — the reason most people buy it — an Oura Ring found no measurable difference at all.
Stanford's SleepFM, published in Nature Medicine in January 2026, is the most consequential sleep paper of the year. Its own limitations section explains why it is not yet a clinical test.
External nasal strips have real, repeatable evidence behind mild snoring relief. They have never been shown to treat sleep apnea, and the two problems are not the same problem.
The practice has real theory behind it and a genuine safety warning attached to it. The studies are small, mostly low quality, and say less than either side of the debate claims.
A review screening 14,125 articles found evidence neither for nor against morning or evening training — only that testing and training at the same hour helps. Evening sessions may cost some sleep continuity.
About a third of adults on two continents wake at least three nights a week. The 7.7% who cannot resume sleep carry almost all of the daytime damage — and the cause is often not what the sleeper thinks.
An umbrella review graded 249 effect sizes across 67 risk factors for male infertility. More than half were rated very low certainty — and the review contradicts its own table on one of them.
In-lab trials that restricted sleep on weekdays and allowed recovery at the weekend found insulin sensitivity and glucose tolerance still worsened. Population surveys point the other way, and the designs explain why.
A Cochrane review found they may not reduce eye strain and could not determine whether they help sleep. A separate meta-analysis found small effects. Neither found the evidence anyone assumes exists.
A 2,836-pair analysis of the ECHO cohort found one of four compounds associated with parent-reported sleep problems. A Shanghai study of bone density found opposite directions in girls and boys.
A laboratory trial found a light-emitting e-reader really does suppress melatonin and delay the body clock. Two 2026 field studies found the day-to-day effect runs almost entirely through when people go to bed.
Two American guideline bodies grade cognitive behavioural therapy for insomnia as a strong recommendation. Every drug in the sleep-medicine guideline — the ones it endorses and the ones it rejects — came out weak.
A consortium reduced overnight sleep studies to nine composites. Two tracked with better cognition. None tracked with whether a person later developed dementia.
A meta-analysis of 44 cohorts covering 1,864,274 people found the risk signal attached to naps of 30 minutes or more. Below that threshold, no significant risk appeared.
The pooled effect is about seven minutes off the time it takes to fall asleep. The American Academy of Sleep Medicine recommends against it — on evidence it grades as weak in both directions.
The number most people quote is not the number the American Academy of Sleep Medicine and Sleep Research Society agreed on. Their recommendation is a floor, set by expert vote rather than by trial.
A Cochrane review found melatonin reduced jet lag in nine of ten trials. Sleep medicine's own guideline rates it a first-tier option for jet lag disorder. Take it at the wrong hour and it can make things worse.
A twelve-athlete study tested morning, late-afternoon and late-evening sessions across the fasting month — and found the deficit was specific to time of day, not spread evenly across it.
Stress peaked during the fasting month and fell afterwards, but depression and anxiety stayed flat. The consistent finding across every phase was that sleep quality tracked mental health.
The sinuses really do produce nitric oxide at concentrations far above the lower airway. Whether routing more of it through your lungs at night does anything measurable is a separate, unanswered question.
The best-validated sleep apnea screener works by being wrong in a specific direction. A 47-study meta-analysis of 26,547 people shows what a questionnaire can and cannot conclude about you.
An analysis of nearly 139,000 Americans finds sedative misuse for sleep clusters among both the socially advantaged and the chronically unwell — pointing to two distinct drivers behind the same behavior.
The NCAA's fifth GOALS study surveyed 20,887 athletes. Sleep is up across almost every sport. Comfort talking to coaches about mental health has barely moved in a decade.
The clearance story about sleep has been brain-centric. A Nature paper reports that in Drosophila, immune cells from the circulation do part of the job — and that blocking them shortens sleep.
Breathing through the mouth in sleep tracks closely with sleep apnea severity. The direction of the arrow is the part the research has not settled, and it changes what any intervention can claim.
A UK Biobank analysis finds high step counts do not offset short sleep. A US cohort finds one-minute bursts matter. And in older adults, most step-count differences vanish after adjusting for age and sex.
The famous Stanford basketball study had eleven players and no control group. Fifteen years on, sleep extension is still the best-supported sleep intervention in sport, and still barely studied.
Among 16-to-24-year-olds in NHANES, those who slept longer on weekends had 41% lower odds of daily depressive symptoms. The survey measured both at the same moment, which limits what can be concluded.
Standard questionnaires found no daytime difference between suvorexant and placebo. Four-times-daily smartphone prompts found fatigue worse in the morning and better later. The trial had 40 people.
A 240-woman randomised trial compared three months of hatha yoga with a time-matched conditioning programme. On every sleep measure, the two groups moved together.
An industry-standard indirect comparison of fezolinetant and elinzanetant found comparable reductions in vasomotor symptoms. Elinzanetant improved sleep disturbance more, without a difference in overall quality of life.
Twenty experts scored three language models on ten common questions. One model cleared the content validity bar on both topics; another scored zero on jet lag.
Forty-two trials show sleep-hygiene education helps a little and helps less than the alternatives. The sleep-medicine guideline suggests clinicians not use it on its own.
Google's PH-LLM beat sampled human experts on multiple-choice tests but only matched them on real cases. A new reporting checklist published the same month explains why such claims are hard to compare.